SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Brain Infarction D020520 17 associated lipids
Stroke D020521 32 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Liu Y et al. Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways. 2014 Chin J Integr Med pmid:24122632
Zhang MY et al. In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation. 2012 Chin J Integr Med pmid:22457138
Pang W et al. Effect of puerarin on the release of interleukin-8 in co-culture of human bronchial epithelial cells and neutrophils. 2012 Chin J Integr Med pmid:22457139
Zhao Y and Zhou Y Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path. 2012 Chin J Integr Med pmid:22457141
Kong H et al. Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction () in Mice. 2018 Chin J Integr Med pmid:25908218
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Liu AC et al. Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats. 2015 Chin J Nat Med pmid:25908622
Wang C et al. The proliferation, differentiation, and mineralization effects of puerarin on osteoblasts in vitro. 2014 Chin J Nat Med pmid:24969524
Wei SY et al. Progress on the pharmacological research of puerarin: a review. 2014 Chin J Nat Med pmid:24969520
Chen G et al. Puerarin attenuates angiotensin II-induced cardiac fibroblast proliferation via the promotion of catalase activity and the inhibition of hydrogen peroxide-dependent Rac-1 activation. 2018 Chin J Nat Med pmid:29425589
Liu AC et al. LC-MS/MS method for the determination of a new puerarin derivative and its application in pharmacokinetic studies in rats. 2013 Chin J Nat Med pmid:24359785
Song J et al. Simultaneous determination of multiple marker constituents in concentrated Gegen Tang granule by high performance liquid chromatography. 2007 Chin Med pmid:17578586
Zhang L et al. Intestinal absorbability of three Radix Puerariae isoflavones including daidzein, daidzin and puerarin. 2011 Chin Med pmid:22108408
Zhang Z et al. Preventive effects of Flos Perariae (Gehua) water extract and its active ingredient puerarin in rodent alcoholism models. 2010 Chin Med pmid:20974012
Su SY and Hsieh CL Anti-inflammatory effects of Chinese medicinal herbs on cerebral ischemia. 2011 Chin Med pmid:21740583
Wong SM et al. Myocardial post-conditioning with Danshen-Gegen decoction protects against isoproterenol-induced myocardial injury via a PKCε/mKATP-mediated pathway in rats. 2011 Chin Med pmid:21320349
Yao M et al. Quantitative analysis of two isoflavones in Pueraria lobata flowers from eleven Chinese provinces using high performance liquid chromatography. 2010 Chin Med pmid:20416072
Sang HF et al. Effect of puerarin on neural function and histopathological damages after transient spinal cord ischemia in rabbits. 2004 Chin. J. Traumatol. pmid:15294110
Fan LL et al. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function. 1992 Chin. Med. J. pmid:1576864
Lu XR et al. Puerarin beta-adrenergic receptor blocking effect. 1987 Chin. Med. J. pmid:2885157
Sheu SY et al. Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice. 2012 Chin. Med. J. pmid:23075718
Fan LL et al. Pharmacologic studies on radix puerariae: effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia. 1985 Chin. Med. J. pmid:3938713
Hao LN et al. Inducible nitric oxide synthase and Fas/FasL with C3 expression of mouse retinal pigment epithelial cells in response to stimulation by peroxynitrite and antagonism of puerarin. 2011 Chin. Med. J. pmid:21933599
Fan LL et al. Protective effect of puerarin against myocardial reperfusion injury. Myocardial metabolism and ultrastructure. 1992 Chin. Med. J. pmid:1451545
Qian Y et al. Blocking effect of puerarin on calcium channel in isolated guinea pig ventricular myocytes. 1999 Chin. Med. J. pmid:11717945
O'Brien KA Alternative perspectives: how chinese medicine understands hypercholesterolemia. 2010 Cholesterol pmid:21490916
Yan H et al. Treating senile dementia with traditional Chinese medicine. 2007 Clin Interv Aging pmid:18044136
Kim Y et al. Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects. 2017 Clin Pharmacol Drug Dev pmid:28301092
Li X et al. Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension. 2017 Clin. Exp. Hypertens. pmid:28060542
Wang D et al. Automated On-Line Microdialysis Sampling Coupled with HPLC for Synchronous Determination of Puerarin in Subcutaneous Tissue and Plasma Following Topical Administration. 2015 Clin. Lab. pmid:26554250
Wang Y et al. Preventive effects of puerarin on alcohol-induced osteonecrosis. 2008 Clin. Orthop. Relat. Res. pmid:18350350
Zhao J et al. Botanical drug puerarin coordinates with nerve growth factor in the regulation of neuronal survival and neuritogenesis via activating ERK1/2 and PI3K/Akt signaling pathways in the neurite extension process. 2015 CNS Neurosci Ther pmid:25310912
Wang Q et al. WITHDRAWN: Puerarin injection for unstable angina pectoris. 2016 Cochrane Database Syst Rev pmid:27136749
Liu B et al. Puerarin for ischaemic stroke. 2016 Cochrane Database Syst Rev pmid:26891451
Wang Q et al. Puerarin injection for unstable angina pectoris. 2006 Cochrane Database Syst Rev pmid:16856037
Tan Y et al. Puerarin for acute ischaemic stroke. 2008 Cochrane Database Syst Rev pmid:18254067
Yi Y et al. The construction of puerarin nanocrystals and its pharmacokinetic and in vivo-in vitro correlation (IVIVC) studies on beagle dog. 2015 Colloids Surf B Biointerfaces pmid:26099971
Weiping S et al. Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin. 2006 Colloids Surf B Biointerfaces pmid:16466908
Gao Q et al. Improvement of ventricular mechanical properties by puerarin involves mitochondrial permeability transition in isolated rat heart during ischemia and reperfusion. 2005 Conf Proc IEEE Eng Med Biol Soc pmid:17281523
Zhang S et al. Application of microdialysis technique in the traditional chinese medicine. 2005 Conf Proc IEEE Eng Med Biol Soc pmid:17282072
Dong K et al. Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta. 2004 Conf Proc IEEE Eng Med Biol Soc pmid:17271112
Fan X et al. Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. 2010 Curr Neuropharmacol pmid:21629441
Lee DY and He M Recent advances in aryl C-glycoside synthesis. 2005 Curr Top Med Chem pmid:16305534
Liu JM et al. [Therapeutic effect of puerarin therapy on sudden deafness]. 2002 Di Yi Jun Yi Da Xue Xue Bao pmid:12433647
Xie W and Du L Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. 2011 Diabetes Obes Metab pmid:21205111
Penetar DM et al. The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study. 2012 Drug Alcohol Depend pmid:22578529
Bacanlı M et al. The antioxidant, cytotoxic, and antigenotoxic effects of galangin, puerarin, and ursolic acid in mammalian cells. 2017 Drug Chem Toxicol pmid:27461151
Huang FJ and Chan WH Apoptotic effects on maturation of mouse oocytes, fertilization and fetal development by puerarin. 2016 Drug Chem Toxicol pmid:26712108
Yi T et al. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. 2017 Drug Deliv pmid:28165806
Li W et al. Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. 2018 Drug Deliv pmid:29587545